Warning: The NCBI web site requires JavaScript to function. more...
Fetching bibliography...
Generate a file for use with external citation management software.
An international collaborative study to compare different von Willebrand factor glycoprotein Ib binding activity assays: the COMPASS-VWF study.
Szederjesi A, Baronciani L, Budde U, Castaman G, Lawrie AS, Liu Y, Montgomery R, Peyvandi F, Schneppenheim R, Várkonyi A, Patzke J, Bodó I.
J Thromb Haemost. 2018 Jun 13. doi: 10.1111/jth.14206. [Epub ahead of print]
Similar articles
Plasma factor XIII level variations during menstrual cycle.
Sharief LA, Lawrie AS, Mackie IJ, Halimeh S, Kappert G, Smith C, Peyvandi F, Kadir RA.
Blood Coagul Fibrinolysis. 2016 Oct;27(7):786-790.
Thrombin generation and factor X assays for the assessment of warfarin anticoagulation in thrombotic antiphospholipid syndrome.
Efthymiou M, Lawrie AS, Mackie I, Arachchillage D, Lane PJ, Machin S, Cohen H.
Thromb Res. 2015 Jun;135(6):1191-7. doi: 10.1016/j.thromres.2015.03.030. Epub 2015 Apr 9.
Rivaroxaban and warfarin achieve effective anticoagulation, as assessed by inhibition of TG and in-vivo markers of coagulation activation, in patients with venous thromboembolism.
Arachchillage DR, Efthymiou M, Mackie IJ, Lawrie AS, Machin SJ, Cohen H.
Thromb Res. 2015 Feb;135(2):388-93. doi: 10.1016/j.thromres.2014.11.037. Epub 2014 Dec 13.
Anti-protein C antibodies are associated with resistance to endogenous protein C activation and a severe thrombotic phenotype in antiphospholipid syndrome.
J Thromb Haemost. 2014 Nov;12(11):1801-9. doi: 10.1111/jth.12722. Epub 2014 Oct 3.
Comparative sensitivity of commonly used thromboplastins to ex vivo therapeutic rivaroxaban levels.
Arachchillage DR, Efthymiou M, Lawrie AS, Machin SJ, Mackie IJ, Cohen H.
Thromb Haemost. 2014 Aug;112(2):421-3. doi: 10.1160/TH14-01-0050. Epub 2014 Mar 27. No abstract available.
Changes in factor XIII level during pregnancy.
Sharief LT, Lawrie AS, Mackie IJ, Smith C, Peyvandi F, Kadir RA.
Haemophilia. 2014 Mar;20(2):e144-8. doi: 10.1111/hae.12345. Epub 2013 Dec 16.
The automation of routine light transmission platelet aggregation.
Lawrie AS, Kobayashi K, Lane PJ, Mackie IJ, Machin SJ.
Int J Lab Hematol. 2014 Aug;36(4):431-8. doi: 10.1111/ijlh.12161. Epub 2013 Nov 14.
A two-centre comparative evaluation of new automated assays for von Willebrand factor ristocetin cofactor activity and antigen.
Stufano F, Lawrie AS, La Marca S, Berbenni C, Baronciani L, Peyvandi F.
Haemophilia. 2014 Jan;20(1):147-53. doi: 10.1111/hae.12264. Epub 2013 Sep 12.
Determination of APTT factor sensitivity--the misguiding guideline.
Lawrie AS, Kitchen S, Efthymiou M, Mackie IJ, Machin SJ.
Int J Lab Hematol. 2013 Dec;35(6):652-7. doi: 10.1111/ijlh.12109. Epub 2013 May 30.
A comparative evaluation of a new automated assay for von Willebrand factor activity.
Lawrie AS, Stufano F, Canciani MT, Mackie IJ, Machin SJ, Peyvandi F.
Haemophilia. 2013 Mar;19(2):338-42. doi: 10.1111/hae.12064. Epub 2012 Dec 4.
Procoagulant activity in patients with sickle cell trait.
Lawrie AS, Pizzey A, Trompeter S, Meiselman H, Mohandas N, Dumanski JP, Westerman MP.
Blood Coagul Fibrinolysis. 2012 Jun;23(4):268-70. doi: 10.1097/MBC.0b013e32835187f8.
Development and application of an automated chromogenic thrombin generation assay that is sensitive to defects in the protein C pathway.
Green L, Safa O, Machin SJ, Mackie IJ, Ryland K, Cohen H, Lawrie AS.
Thromb Res. 2012 Nov;130(5):780-4. doi: 10.1016/j.thromres.2011.12.034. Epub 2012 Jan 20.
The effect of total hip/knee replacement surgery and prophylactic dabigatran on thrombin generation and coagulation parameters.
Green L, Lawrie AS, Patel R, Stephens RC, Mackie IJ, Chitolie A, Haddad FS, Machin SJ.
Thromb Res. 2012 Nov;130(5):775-9. doi: 10.1016/j.thromres.2011.12.023. Epub 2012 Jan 14.
The clinical significance of differences between point-of-care and laboratory INR methods in over-anticoagulated patients.
Lawrie AS, Hills J, Longair I, Green L, Gardiner C, Machin SJ, Cohen H.
Thromb Res. 2012 Jul;130(1):110-4. doi: 10.1016/j.thromres.2011.08.027. Epub 2011 Sep 19.
Persistent high factor VIII activity leading to increased thrombin generation - a prospective cohort study.
Ryland JK, Lawrie AS, Mackie IJ, Machin SJ.
Thromb Res. 2012 Apr;129(4):447-52. doi: 10.1016/j.thromres.2011.07.020. Epub 2011 Aug 16.
Idiopathic noncirrhotic intrahepatic portal hypertension is associated with sustained ADAMTS13 Deficiency.
Mackie I, Eapen CE, Neil D, Lawrie AS, Chitolie A, Shaw JC, Elias E.
Dig Dis Sci. 2011 Aug;56(8):2456-65. doi: 10.1007/s10620-011-1729-4. Epub 2011 May 15.
Evaluation of an automated platelet-based assay of ristocetin cofactor activity.
Lawrie AS, Mackie IJ, Machin SJ, Peyvandi F.
Haemophilia. 2011 Mar;17(2):252-6. doi: 10.1111/j.1365-2516.2010.02419.x. Epub 2010 Nov 11.
The impact of elective knee/hip replacement surgery and thromboprophylaxis with rivaroxaban or dalteparin on thrombin generation.
Green L, Lawrie AS, Patel S, Hossain F, Chitolie A, Mackie IJ, Haddad FS, Machin SJ.
Br J Haematol. 2010 Dec;151(5):469-76. doi: 10.1111/j.1365-2141.2010.08433.x. Epub 2010 Oct 18.
The effect of prion reduction in solvent/detergent-treated plasma on haemostatic variables.
Lawrie AS, Green L, Canciani MT, Mackie IJ, Peyvandi F, Scully MA, Machin SJ.
Vox Sang. 2010 Oct;99(3):232-8. doi: 10.1111/j.1423-0410.2010.01346.x.
Factor XIII--an under diagnosed deficiency--are we using the right assays?
Lawrie AS, Green L, Mackie IJ, Liesner R, Machin SJ, Peyvandi F.
J Thromb Haemost. 2010 Nov;8(11):2478-82. doi: 10.1111/j.1538-7836.2010.04028.x.
Microparticle sizing by dynamic light scattering in fresh-frozen plasma.
Lawrie AS, Albanyan A, Cardigan RA, Mackie IJ, Harrison P.
Vox Sang. 2009 Apr;96(3):206-12. doi: 10.1111/j.1423-0410.2008.01151.x. Epub 2009 Jan 19.
The characterization and impact of microparticles on haemostasis within fresh-frozen plasma.
Lawrie AS, Harrison P, Cardigan RA, Mackie IJ.
Vox Sang. 2008 Oct;95(3):197-204. doi: 10.1111/j.1423-0410.2008.01081.x.
The VWF/ADAMTS13 axis in the antiphospholipid syndrome: ADAMTS13 antibodies and ADAMTS13 dysfunction.
Austin SK, Starke RD, Lawrie AS, Cohen H, Machin SJ, Mackie IJ.
Br J Haematol. 2008 May;141(4):536-44. doi: 10.1111/j.1365-2141.2008.07074.x. Epub 2008 Mar 12.
The dynamics of clot formation in fresh-frozen plasma.
Lawrie AS, Cardigan RA, Williamson LM, Machin SJ, Mackie IJ.
Vox Sang. 2008 May;94(4):306-14. doi: 10.1111/j.1423-0410.2008.01037.x. Epub 2008 Feb 5.
Coagulation factor levels in cryosupernatant prepared from plasma treated with amotosalen hydrochloride (S-59) and ultraviolet A light.
Yarranton H, Lawrie AS, Mackie IJ, Pinkoski L, Corash L, Machin SJ.
Transfusion. 2005 Sep;45(9):1453-8.
Increased platelet count and leucocyte-platelet complex formation in acute symptomatic compared with asymptomatic severe carotid stenosis.
McCabe DJ, Harrison P, Mackie IJ, Sidhu PS, Purdy G, Lawrie AS, Watt H, Machin SJ, Brown MM.
J Neurol Neurosurg Psychiatry. 2005 Sep;76(9):1249-54.
The quality of fresh-frozen plasma produced from whole blood stored at 4 degrees C overnight.
Cardigan R, Lawrie AS, Mackie IJ, Williamson LM.
Transfusion. 2005 Aug;45(8):1342-8.
Assessment of the antiplatelet effects of low to medium dose aspirin in the early and late phases after ischaemic stroke and TIA.
McCabe DJ, Harrison P, Mackie IJ, Sidhu PS, Lawrie AS, Purdy G, Machin SJ, Brown MM.
Platelets. 2005 Aug;16(5):269-80.
Platelet degranulation and monocyte-platelet complex formation are increased in the acute and convalescent phases after ischaemic stroke or transient ischaemic attack.
McCabe DJ, Harrison P, Mackie IJ, Sidhu PS, Purdy G, Lawrie AS, Watt H, Brown MM, Machin SJ.
Br J Haematol. 2004 Jun;125(6):777-87.
Comparison of von Willebrand factor antigen, von Willebrand factor-cleaving protease and protein S in blood components used for treatment of thrombotic thrombocytopenic purpura.
Yarranton H, Lawrie AS, Purdy G, Mackie IJ, Machin SJ.
Transfus Med. 2004 Feb;14(1):39-44.
A multicentre assessment of the endogenous thrombin potential using a continuous monitoring amidolytic technique.
Lawrie AS, Gray E, Leeming D, Davidson SJ, Purdy G, Iampietro R, Craig S, Rigsby P, Mackie IJ.
Br J Haematol. 2003 Oct;123(2):335-41.
A performance evaluation of commercial fibrinogen reference preparations and assays for Clauss and PT-derived fibrinogen.
Mackie J, Lawrie AS, Kitchen S, Gaffney PJ, Howarth D, Lowe GD, Martin J, Purdy G, Rigsby P, Rumley A.
Thromb Haemost. 2002 Jun;87(6):997-1005.
Effect of lupus anticoagulants on INR with different thromboplastins.
Lawrie AS, Mackie IJ, Purdy G, Machin SJ.
Blood Coagul Fibrinolysis. 2001 Apr;12(3):221. No abstract available.
The impact of oral anticoagulant therapy, factor VIII level and quality of factor V-deficient plasma on three commercial methods for activated protein C resistance.
Chitolie A, Lawrie AS, Mackie IJ, Harrison P, Machin SJ.
Blood Coagul Fibrinolysis. 2001 Apr;12(3):179-86.
Von Willebrand factor--cleaving protease activity in congenital thrombotic thrombocytopenic purpura.
Allford SL, Harrison P, Lawrie AS, Liesner R, MacKie IJ, Machin SJ.
Br J Haematol. 2000 Dec;111(4):1215-22.
The sensitivity and specificity of commercial reagents for the detection of lupus anticoagulant show marked differences in performance between photo-optical and mechanical coagulometers.
Thromb Haemost. 1999 May;81(5):758-62.
Prothrombin time derived fibrinogen determination on Sysmex CA-6000.
Lawrie AS, McDonald SJ, Purdy G, Mackie IJ, Machin SJ.
J Clin Pathol. 1998 Jun;51(6):462-6.
Assessment of Actin FS and Actin FSL sensitivity to specific clotting factor deficiencies.
Lawrie AS, Kitchen S, Purdy G, Mackie IJ, Preston FE, Machin SJ.
Clin Lab Haematol. 1998 Jun;20(3):179-86.
Monitoring of oral anticoagulant therapy in lupus anticoagulant positive patients with the anti-phospholipid syndrome.
Lawrie AS, Purdy G, Mackie IJ, Machin SJ.
Br J Haematol. 1997 Sep;98(4):887-92.
Cryoprecipitate prepared from plasma virally inactivated by the solvent detergent method.
Keeling DM, Luddington R, Allain JP, Lawrie AS, Williamson LM.
Br J Haematol. 1997 Jan;96(1):194-7.
Plasma exchange with solvent/detergent-treated plasma of resistant thrombotic thrombocytopenic purpura.
Harrison CN, Lawrie AS, Iqbal A, Hunter A, Machin SJ.
Br J Haematol. 1996 Sep;94(4):756-8.
Near patient testing (NPT) in haemostasis--a synoptic review.
Machin SJ, Mackie IJ, Chitolie A, Lawrie AS.
Clin Lab Haematol. 1996 Jun;18(2):69-74. No abstract available.
Assay of protein S in systemic lupus erythematosus.
Lawrie AS, Lloyd ME, Mohamed F, Irons S, Hughes GR, Savidge GF.
Blood Coagul Fibrinolysis. 1995 Jun;6(4):322-4.
Primary thrombocythaemia: a composite approach to diagnosis.
Messinezy M, Westwood N, Sawyer B, Grace R, Holland LJ, Lawrie AS, Pearson TC.
Clin Lab Haematol. 1994 Jun;16(2):139-48.
Exercise induced release of von Willebrand factor: evidence for hypoxic reperfusion microvascular injury in rheumatoid arthritis.
Farrell AJ, Williams RB, Stevens CR, Lawrie AS, Cox NL, Blake DR.
Ann Rheum Dis. 1992 Oct;51(10):1117-22.
Evidence of discrepant commercial ISI assignment.
Holland LJ, Lawrie AS, Hunt BJ.
Blood Coagul Fibrinolysis. 1992 Aug;3(4):493-4; author reply 495. No abstract available.
TDM35--a new monoclonal antibody to the XH1 cervical carcinoma cell line. Characterization and immunoperoxidase localization in benign and malignant tissues.
Chana T, Han X, Dagg B, Lawrie AS, Gooding RP, Eustace DL, Fletcher CD, Heyderman E.
J Pathol. 1992 Aug;167(4):391-7.
Absence of the gamma-Leu 427 (gamma') variant in the platelet alpha-granular fibrinogen pool supports the role of glycoprotein IIB/IIIA in mediating fibrinogen uptake into platelets/megakaryocytes.
Harrison P, Wilbourn BR, Saundry RH, Lawrie AS, Savidge GF.
Blood. 1992 Jun 15;79(12):3394-5. No abstract available.
Pregnancy in congenital afibrinogenaemia: report of a successful case and review of the literature.
Grech H, Majumdar G, Lawrie AS, Savidge GF.
Br J Haematol. 1991 Aug;78(4):571-2. No abstract available.
Filters: Manage Filters